2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
12
Cognitive Dysfunction
4
Radiation Injuries
3
Neoplasms
3
Multiple Myeloma
3
Glioma
3
Breast Neoplasms
3
Lymphoma, B-Cell
2
Lymphoma
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Astrocytoma
2
Triple Negative Breast Neoplasms
1
Stroke
1
Sarcoma
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Parkinson Disease
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Cyclophosphamide
35
Temozolomide
33
Filgrastim
26
Etoposide
26
Carboplatin
25
Vincristine
22
Cisplatin
22
Radiotherapy
20
Magnetic Resonance Spectroscopy
18
Thiotepa
14
Irinotecan
13
Granulocyte Colony-Stimulating Factor
12
Peripheral Blood Stem Cell Transplantation
11
Lomustine
11
Specimen Handling
9
Radiation
9
Melphalan
9
etoposide phosphate
8
Topotecan
8
Methotrexate
8
X-Rays
7
Platinum
7
Phantoms, Imaging
7
sonidegib
6
Biopsy
6
1,2-diaminocyclohexaneplatinum II citrate
6
sargramostim
5
palbociclib
5
Nuclear Medicine Department, Hospital
5
HhAntag691
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Neuropsychological Tests
×
Clear all
NCT04174820
2020-11-19
CervIRM
University Hospital, Angers
Unknown
145 enrolled